Terms: = Lung cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310
23 results:
1. Spermatid perinuclear RNA-binding protein promotes ubr5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.
Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
[TBL] [Abstract] [Full Text] [Related]
2. The Ethanolic Extract of
Park HJ; Park SH
Nutr Cancer; 2024; 76(3):305-315. PubMed ID: 38185896
[No Abstract] [Full Text] [Related]
3. Targeting ubr5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract] [Full Text] [Related]
4. CircMAN1A2 contributes to nasopharyngeal carcinoma progression via enhancing the ubiquitination of ATMIN through miR-135a-3p/ubr5 axis.
Dang QQ; Li PH; Wang J; Zhao JY; Zhai SN; Zheng YJ; Yang DK
Hum Cell; 2023 Mar; 36(2):657-675. PubMed ID: 36626032
[TBL] [Abstract] [Full Text] [Related]
5. Exosomal microRNAs array sensor with a bioconjugate composed of p53 protein and hydrazine for the specific lung cancer detection.
Mahmudunnabi RG; Umer M; Seo KD; Park DS; Chung JH; Shiddiky MJA; Shim YB
Biosens Bioelectron; 2022 Jul; 207():114149. PubMed ID: 35290882
[TBL] [Abstract] [Full Text] [Related]
6. Emerging role of circular RNAs in the pathobiology of lung cancer.
Ghafouri-Fard S; Dinger ME; Maleki P; Taheri M; Hajiesmaeili M
Biomed Pharmacother; 2021 Sep; 141():111805. PubMed ID: 34120067
[TBL] [Abstract] [Full Text] [Related]
7. ubr5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway.
Gu YF; Ge XP
J Investig Med; 2021 Jun; 69(5):970-975. PubMed ID: 33811132
[TBL] [Abstract] [Full Text] [Related]
8. Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis.
Song Y; Li L; Chen J; Chen H; Cui B; Feng Y; Zhang P; Zhang Q; Xia Y; Luo M
Cell Cycle; 2020 Dec; 19(24):3521-3533. PubMed ID: 33315498
[TBL] [Abstract] [Full Text] [Related]
9. UBR-box containing protein, ubr5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract] [Full Text] [Related]
10. Independent calculation-based verification of volumetric-modulated arc therapy-stereotactic body radiotherapy plans for lung cancer.
Ono T; Mitsuyoshi T; Shintani T; Tsuruta Y; Iramina H; Hirashima H; Miyabe Y; Nakamura M; Matsuo Y; Mizowaki T
J Appl Clin Med Phys; 2020 Jul; 21(7):135-143. PubMed ID: 32391645
[TBL] [Abstract] [Full Text] [Related]
11. lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.
Cao C; Wang Q; Liu Y
Drug Des Devel Ther; 2019; 13():1087-1098. PubMed ID: 31118562
[No Abstract] [Full Text] [Related]
12. Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab.
Wang D; Xu Q; Yuan Q; Jia M; Niu H; Liu X; Zhang J; Young CY; Yuan H
Oncogene; 2019 May; 38(18):3458-3474. PubMed ID: 30647455
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric lung adenocarcinoma presenting with brain metastasis: a case report.
De Martino L; Errico ME; Ruotolo S; Cascone D; Chiaravalli S; Collini P; Ferrari A; Muto P; Cinalli G; Quaglietta L
J Med Case Rep; 2018 Sep; 12(1):243. PubMed ID: 30172261
[TBL] [Abstract] [Full Text] [Related]
14. Circ-ubr5: An exonic circular RNA and novel small nuclear RNA involved in RNA splicing.
Qin M; Wei G; Sun X
Biochem Biophys Res Commun; 2018 Sep; 503(2):1027-1034. PubMed ID: 29944885
[TBL] [Abstract] [Full Text] [Related]
15. E3 Ubiquitin Ligase ubr5 Drives the Growth and Metastasis of Triple-Negative Breast cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract] [Full Text] [Related]
16. Enrollment Trends and Disparity Among Patients With lung cancer in National Clinical Trials, 1990 to 2012.
Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
[TBL] [Abstract] [Full Text] [Related]
17. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a recurrent transforming ubr5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lung RW; Hui AB; Yip KY; Woo JK; Chow C; Tong CY; Lee SD; Yuen JW; Lun SW; Tso KK; Wong N; Tsao SW; Yip TT; Busson P; Kim H; Seo JS; O'Sullivan B; Liu FF; To KF; Lo KW
J Pathol; 2013 Oct; 231(2):158-67. PubMed ID: 23878065
[TBL] [Abstract] [Full Text] [Related]
19. Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer.
Metro G; Chiari R; Baldi A; De Angelis V; Minotti V; Crinò L
Future Oncol; 2013 Feb; 9(2):167-77. PubMed ID: 23414467
[TBL] [Abstract] [Full Text] [Related]
20. A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis.
Dompe N; Rivers CS; Li L; Cordes S; Schwickart M; Punnoose EA; Amler L; Seshagiri S; Tang J; Modrusan Z; Davis DP
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E943-51. PubMed ID: 21949371
[TBL] [Abstract] [Full Text] [Related]
[Next]
